DFX Intelligence

Venture Capital Intelligence

Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Jnana Therapeutics Inc.

Jnana Therapeutics Inc.

Stage unknownBoston, MABiotechnology

Facts

Year of incorporation: unknown
Revenue range (Form D): Decline to Disclosesec.gov
Rounds on record: 1
Disclosed raised: unknownsum of rounds with a disclosed amount only
Named investors: 2

Financing history

1 rounds

Nov 2, 2022
Form D equity offering · $107M (form d sold) · 8 investors
Fact SEC EDGAR Form D data sets (quarterly) · “Jnana Therapeutics Inc. filed Form D/A: $106,999,997 sold of $106,999,997, Biotechnology”

Investors on record

2 edges

RA Capital Management, LP portfolio listing Fact racap.com
Polaris Partners board only, Terrance G Mcguire (strongly supported) Inference sec.gov

People

4 officers, 7 directors

Caroline Stark Beer Chief Business Officer sec.gov
Douglas W. Pagan Chief Financial Officer and Chief Operating Officer sec.gov
George W. Vratsanos Chief Medical Officer and Head of R&D sec.gov
Joanne D. Kotz Chief Executive Officer, Treasurer, Secretary and Director sec.gov
Donald W. Nicholson Director Fact
Annie C. Chen Director Fact
Ronald C. Renaud, Jr. Director Fact
Carlo W. Rizzuto Director Fact
Terrance G Mcguire Director Inference
Matthew W. Hammond Director Fact
Brian M. Cali Director Fact

Timeline

Jan 26, 2024
Jnana Therapeutics Inc. filed Form D/A: $106,999,997 sold of $106,999,997, Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)

Evidence

16 observations

Every observation on this company

Entity type: Corporation Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: true Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): Decline to Disclose Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: overFiveYears Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $107M Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Offering amount (Form D): $107M Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2022-11-02 Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 8 Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 0 Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Office address: One Design Center Place, Suite 19-400, BOSTON, MA, 02210 Jan 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Listed on portfolio page: RA Capital Management, LP Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Listed on portfolio page: RA Capital Management, LP Sep 15, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)